---
figid: PMC3926869__onci-2-e26961-g1
figlink: /pmc/articles/PMC3926869/figure/F1/
number: F1
caption: Figure 1. The mTOR pathway is involved in both cancer and senescence. Growth
  factors, cytokines, insulin, nutrients, and oncoproteins activate the phosphoinositide-3-kinase/mammalian
  target of rapamycin (PI3K/mTOR) signaling pathway, which promotes cellular growth
  and cell cycle progression. Mutations that results in constitutive activation of
  the mTOR pathway are involved in oncogenic transformation when intrinsic controls
  on cell cycle progression are disabled. Conversely, when mTOR is activated and the
  cell cycle is arrested, cells enter a senescent state. Rapamycin and other rapalogs
  (e.g., everolimus) inhibit the mTOR complex 1 (mTORC1) and suppress such a geroconversion.
pmcid: PMC3926869
papertitle: Immunosuppressants in cancer prevention and therapy.
reftext: Mikhail V Blagosklonny. Oncoimmunology. 2013 Dec 1;2(12):e26961.
pmc_ranked_result_index: '673'
pathway_score: 0.9398514
filename: onci-2-e26961-g1.jpg
figtitle: Immunosuppressants in cancer prevention and therapy
year: '2013'
organisms: Homo sapiens
ndex: 16f2eb71-de9a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3926869__onci-2-e26961-g1.html
  '@type': Dataset
  description: Figure 1. The mTOR pathway is involved in both cancer and senescence.
    Growth factors, cytokines, insulin, nutrients, and oncoproteins activate the phosphoinositide-3-kinase/mammalian
    target of rapamycin (PI3K/mTOR) signaling pathway, which promotes cellular growth
    and cell cycle progression. Mutations that results in constitutive activation
    of the mTOR pathway are involved in oncogenic transformation when intrinsic controls
    on cell cycle progression are disabled. Conversely, when mTOR is activated and
    the cell cycle is arrested, cells enter a senescent state. Rapamycin and other
    rapalogs (e.g., everolimus) inhibit the mTOR complex 1 (mTORC1) and suppress such
    a geroconversion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3R5
  - PIK3CD
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - FBN1
  - PIK3CG
  - PIK3R6
  - RPTOR
  - MTOR
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: mass
  symbol: MASS
  source: hgnc_alias_symbol
  hgnc_symbol: FBN1
  entrez: '2200'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals: []
diseases: []
figid_alias: PMC3926869__F1
redirect_from: /figures/PMC3926869__F1
figtype: Figure
---
